Rafiq A Sheikh

Summary

Publications

  1. ncbi request reprint Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs and controls
    Rafiq A Sheikh
    Division of Gastroenterology, Department of Medicine, University of California Davis Medical Center, Sacramento, CA, USA
    J Clin Gastroenterol 34:529-32. 2002
  2. ncbi request reprint Screening preferences for colorectal cancer: a patient demographic study
    Rafiq A Sheikh
    San Joaquin General Hospital, Stockton, CA, USA
    South Med J 97:224-30. 2004
  3. pmc Crohn's disease associated with Sweet's syndrome and Sjögren's syndrome treated with infliximab
    Erina N Foster
    Division of Gastroenterology and Hepatology, University of California at Davis Medical Center, Sacramento, CA, USA
    Clin Dev Immunol 12:145-9. 2005
  4. ncbi request reprint Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas
    Rafiq A Sheikh
    Department of Gastroenterology, University of California Davis Medical Center, Davis, California, USA
    Dig Dis Sci 48:223-9. 2003
  5. pmc Unusual presentations of eosinophilic gastroenteritis: case series and review of literature
    Rafiq A Sheikh
    Department of Gastroenterology, Kaiser Permanente Medical Center, 6600 Bruceville Road, Sacramento, CA 95823, USA
    World J Gastroenterol 15:2156-61. 2009

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs and controls
    Rafiq A Sheikh
    Division of Gastroenterology, Department of Medicine, University of California Davis Medical Center, Sacramento, CA, USA
    J Clin Gastroenterol 34:529-32. 2002
    ..We studied the endoscopic evidence of mucosal damage in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs (NSAIDs) and matched controls...
  2. ncbi request reprint Screening preferences for colorectal cancer: a patient demographic study
    Rafiq A Sheikh
    San Joaquin General Hospital, Stockton, CA, USA
    South Med J 97:224-30. 2004
    ..Despite endorsement by academic and health care organizations, patient awareness and compliance with screening is low, partly because of patient-related barriers to screening...
  3. pmc Crohn's disease associated with Sweet's syndrome and Sjögren's syndrome treated with infliximab
    Erina N Foster
    Division of Gastroenterology and Hepatology, University of California at Davis Medical Center, Sacramento, CA, USA
    Clin Dev Immunol 12:145-9. 2005
    ..Both cases responded rapidly to Infliximab therapy with complete resolution of the skin lesions...
  4. ncbi request reprint Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas
    Rafiq A Sheikh
    Department of Gastroenterology, University of California Davis Medical Center, Davis, California, USA
    Dig Dis Sci 48:223-9. 2003
    ..Adnab-9 antibody may identify a field defect in above-average-risk adenoma-bearing patients...
  5. pmc Unusual presentations of eosinophilic gastroenteritis: case series and review of literature
    Rafiq A Sheikh
    Department of Gastroenterology, Kaiser Permanente Medical Center, 6600 Bruceville Road, Sacramento, CA 95823, USA
    World J Gastroenterol 15:2156-61. 2009
    ..Gastric outlet and/or small bowel obstruction is an important though uncommon presentation of EG. It may also present as esophagitis, gastritis with polypoid lesions, ulcers or erosions, colitis and pancreatitis and may mimic malignancy...